Sanjiu Pharmaceutical Implements Purchase Plan

Help | Sitemap | Archive | Advanced Search | Mirror in USA



CHINA BUSINESS OPINION WORLD SCI-EDU SPORTS LIFE WAP SERVICE FEATURES PHOTO GALLERY
	INTERACTIVE
	Message Board
	Feedback
	Voice of Readers
	China Quiz





	China At a Glance
	Constitution of the PRC
	State Organs of the PRC
	CPC and State Leaders
	Chinese President Jiang Zemin
	White Papers of Chinese Government
	Selected Works of Deng Xiaoping
	English Websites in China



	Help About Us SiteMap Employment
	MIRROR

	U.S. Mirror Japan Mirror Tech-Net Mirror Edu-Net Mirror

Saturday, September 02, 2000, updated at 10:22(GMT+8)

Business

Sanjiu Pharmaceutical Implements Purchase Plan

Sanjiu Pharmaceutical Co., Ltd. is busily implementing its purchase plan used capital raised.

Sanjiu Pharmaceutical recently signed purchase agreement with the relative shareholders to formally take over 100% asset equity of Sanjiu Huangshi Pharmaceutical Factory, 65% share equity of Beijing Sanjiu Wandong Pharmaceutical Co., Ltd., 50.1% share equity of Ningbo Medical Material Co., Ltd., 50.5% share equity of Changsha Sanjiu Medicine Co., Ltd. and 51% share equity of Quzhou Medicine Co., Ltd. The above purchases are all realized with the capital raised.

Reportedly after the realization of the 5 purchases, Sanjiu will avoid the competition of the same trade with the controlling shareholders. At the same time, the company will enrich the product structure, rally the sales net and extend the company's market share. (Panorama)


Print	Discuss It	Recommend to your friend

In This Section



	Sanjiu Pharmaceutical recently signed purchase agreement with the relative shareholders to formally take over 100% asset equity of Sanjiu Huangshi Pharmaceutical Factory, 65% share equity of Beijing Sanjiu Wandong Pharmaceutical Co., Ltd., 50.1% share equity of Ningbo Medical Material Co., Ltd., 50.5% share equity of Changsha Sanjiu Medicine Co., Ltd. and 51% share equity of Quzhou Medicine Co., Ltd.




Advanced Search


	Pharmaceutical Industry Opened Wider to Foreign Investors China to Strengthen Pharmaceutical Control